Register for a JAX webinar: Modeling Human Malignancy with Patient-derived Xenograft Cancer Models

 

Jackson Laboratory Webinars

Modeling Human Malignancy with Patient-derived Xenograft Cancer Models

Date: July 26, 2012 Time: 10am PT / 11am MT / 12pm CT / 1pm ET* Patient-derived xenograft (PDX) cancer models show great promise as preclinical models that reflect the heterogeneity of human cancer. The JAX PDX program was developed in collaboration with renowned cancer hospitals to advance the course of preclinical drug development. *Time/date conversions (New York City is in the ET (Eastern Time) zone)

©2012 The Jackson Laboratory| Manage Subscriptions |Privacy Policy Leading the Search for Tomorrow's Cures The Jackson Laboratory, 610 Main Street, Bar Harbor ME 04609

You have received this email because you registered at BioSpace. BioSpace regularly sends emails to active subscribers on behalf of our advertising partners or to promote our own products and services. If you would like to stop receiving all email communications from BioSpace, you can unsubscribe at any time by clicking here. BioSpace 6465 South Greenwood Plaza, Suite 400, Centennial, CO 80111, U.S. (888) BIOSPACE